Product Code: ETC8846634 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The neuropathic pain market in the Philippines is expanding as the prevalence of conditions such as diabetes, nerve injuries, and post-surgical pain increases. The demand for pain management therapies, including anticonvulsants, antidepressants, and nerve blocks, is rising. The introduction of non-invasive treatments such as transcutaneous electrical nerve stimulation (TENS) and laser therapy is also driving market expansion.
The rising prevalence of chronic neuropathic pain conditions, including diabetic neuropathy and post-herpetic neuralgia, fuels the neuropathic pain market in the Philippines. Increasing awareness of pain management strategies and the availability of novel analgesics drive market expansion. Additionally, advancements in neuromodulation techniques and alternative therapies support long-term pain relief solutions.
The neuropathic pain market in the Philippines is affected by underdiagnosis and inadequate pain management solutions. Many cases of chronic neuropathic pain remain undetected due to a lack of awareness among both patients and healthcare providers. Existing pain management treatments, such as opioids and anticonvulsants, are either costly or have significant side effects, leading to poor patient adherence. Additionally, access to specialized pain clinics is limited outside urban areas.
The increasing prevalence of diabetes, chemotherapy-induced neuropathy, and spinal cord injuries has driven demand for neuropathic pain treatments in the Philippines. Investors can explore opportunities in novel analgesics, cannabinoid-based therapies, and neuromodulation techniques. Companies developing personalized pain management solutions and AI-driven pain assessment tools can gain traction in the growing healthcare market.
Neuropathic pain management is included in the governments public health initiatives, ensuring affordable access to pain relief medications. The DOH promotes non-pharmacological treatments, such as physical therapy and alternative medicine, alongside conventional drug therapies. Policies also support physician training to improve the diagnosis and management of neuropathic pain.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Neuropathic Pain Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Neuropathic Pain Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Neuropathic Pain Market - Industry Life Cycle |
3.4 Philippines Neuropathic Pain Market - Porter's Five Forces |
3.5 Philippines Neuropathic Pain Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Philippines Neuropathic Pain Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Philippines Neuropathic Pain Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.8 Philippines Neuropathic Pain Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.9 Philippines Neuropathic Pain Market Revenues & Volume Share, By Modality, 2021 & 2031F |
3.10 Philippines Neuropathic Pain Market Revenues & Volume Share, By Mode of Purchase, 2021 & 2031F |
3.11 Philippines Neuropathic Pain Market Revenues & Volume Share, By Pain Type, 2021 & 2031F |
4 Philippines Neuropathic Pain Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Neuropathic Pain Market Trends |
6 Philippines Neuropathic Pain Market, By Types |
6.1 Philippines Neuropathic Pain Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Neuropathic Pain Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Philippines Neuropathic Pain Market Revenues & Volume, By Spinal Cord Stimulation (SCS) Devices, 2021- 2031F |
6.1.4 Philippines Neuropathic Pain Market Revenues & Volume, By External Peripheral Nerve Stimulation, 2021- 2031F |
6.1.5 Philippines Neuropathic Pain Market Revenues & Volume, By Transcutaneous Electrical Nerve Stimulation (Tens) Devices, 2021- 2031F |
6.2 Philippines Neuropathic Pain Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Philippines Neuropathic Pain Market Revenues & Volume, By Rechargeable and Non-Rechargeable, 2021- 2031F |
6.3 Philippines Neuropathic Pain Market, By Procedure |
6.3.1 Overview and Analysis |
6.3.2 Philippines Neuropathic Pain Market Revenues & Volume, By Invasive and Non-Invasive, 2021- 2031F |
6.4 Philippines Neuropathic Pain Market, By Technology |
6.4.1 Overview and Analysis |
6.4.2 Philippines Neuropathic Pain Market Revenues & Volume, By Transcutaneous Electrical Nerve Stimulation, 2021- 2031F |
6.4.3 Philippines Neuropathic Pain Market Revenues & Volume, By Transcranial Magnetic Stimulation, 2021- 2031F |
6.4.4 Philippines Neuropathic Pain Market Revenues & Volume, By Respiratory Electrical Stimulation, 2021- 2031F |
6.5 Philippines Neuropathic Pain Market, By Modality |
6.5.1 Overview and Analysis |
6.5.2 Philippines Neuropathic Pain Market Revenues & Volume, By Stationary, 2021- 2031F |
6.5.3 Philippines Neuropathic Pain Market Revenues & Volume, By Portable, 2021- 2031F |
6.6 Philippines Neuropathic Pain Market, By Mode of Purchase |
6.6.1 Overview and Analysis |
6.6.2 Philippines Neuropathic Pain Market Revenues & Volume, By Over-the-Counter Devices, 2021- 2031F |
6.6.3 Philippines Neuropathic Pain Market Revenues & Volume, By Prescription-Based Devices, 2021- 2031F |
6.7 Philippines Neuropathic Pain Market, By Pain Type |
6.7.1 Overview and Analysis |
6.7.2 Philippines Neuropathic Pain Market Revenues & Volume, By Peripheral Neuropathy, 2021- 2031F |
6.7.3 Philippines Neuropathic Pain Market Revenues & Volume, By Entrapment Neuropathy, 2021- 2031F |
6.7.4 Philippines Neuropathic Pain Market Revenues & Volume, By Trigeminal Neuralgia, 2021- 2031F |
6.7.5 Philippines Neuropathic Pain Market Revenues & Volume, By Trigeminal Neuralgia, 2021- 2031F |
6.7.6 Philippines Neuropathic Pain Market Revenues & Volume, By Post Herpetic Neuralgia (PHN), 2021- 2031F |
6.7.7 Philippines Neuropathic Pain Market Revenues & Volume, By Post Traumatic Neuropathy, 2021- 2031F |
6.7.8 Philippines Neuropathic Pain Market Revenues & Volume, By Coccydynia, 2021- 2031F |
6.7.9 Philippines Neuropathic Pain Market Revenues & Volume, By Coccydynia, 2021- 2031F |
6.8 Philippines Neuropathic Pain Market, By Indication |
6.8.1 Overview and Analysis |
6.8.2 Philippines Neuropathic Pain Market Revenues & Volume, By Spinal Stenosis, 2021- 2031F |
6.8.3 Philippines Neuropathic Pain Market Revenues & Volume, By Chemotherapy-Induced Peripheral Neuropathy, 2021- 2031F |
6.8.4 Philippines Neuropathic Pain Market Revenues & Volume, By Others, 2021- 2031F |
6.8.5 Philippines Neuropathic Pain Market Revenues & Volume, By Others, 2021- 2031F |
7 Philippines Neuropathic Pain Market Import-Export Trade Statistics |
7.1 Philippines Neuropathic Pain Market Export to Major Countries |
7.2 Philippines Neuropathic Pain Market Imports from Major Countries |
8 Philippines Neuropathic Pain Market Key Performance Indicators |
9 Philippines Neuropathic Pain Market - Opportunity Assessment |
9.1 Philippines Neuropathic Pain Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Philippines Neuropathic Pain Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Philippines Neuropathic Pain Market Opportunity Assessment, By Procedure, 2021 & 2031F |
9.4 Philippines Neuropathic Pain Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.5 Philippines Neuropathic Pain Market Opportunity Assessment, By Modality, 2021 & 2031F |
9.6 Philippines Neuropathic Pain Market Opportunity Assessment, By Mode of Purchase, 2021 & 2031F |
9.7 Philippines Neuropathic Pain Market Opportunity Assessment, By Pain Type, 2021 & 2031F |
9.7 Philippines Neuropathic Pain Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Philippines Neuropathic Pain Market - Competitive Landscape |
10.1 Philippines Neuropathic Pain Market Revenue Share, By Companies, 2024 |
10.2 Philippines Neuropathic Pain Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |